| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/27/2006 | CN1838956A 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds |
| 09/27/2006 | CN1838955A Flupirtine preparation for treating neurodegenerative disorders of the visual system and diabetes mellitus |
| 09/27/2006 | CN1838954A Glycogen synthase kinase-3 inhibitors |
| 09/27/2006 | CN1838953A 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases |
| 09/27/2006 | CN1838952A Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 09/27/2006 | CN1838951A Bicycl 3.1.1]heptane substituted benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors |
| 09/27/2006 | CN1838950A Methods for treating protein aggregation disorders |
| 09/27/2006 | CN1838949A Pharmaceutical composition comprising a combination of metformin and a statin |
| 09/27/2006 | CN1838948A Methods and compositions for delivery of catecholic butanes for treatment of diseases |
| 09/27/2006 | CN1838947A Glycyrrhizin or derivatives thereof for treating or preventing severe acute respiratory syndrome (SARS) |
| 09/27/2006 | CN1838946A Pharmaceutical formulations of amyloid inhibiting compounds |
| 09/27/2006 | CN1838945A Novel formulation of ropinirole |
| 09/27/2006 | CN1838944A Method for deterring abuse of opioids by combination with non-release formulation of emetic |
| 09/27/2006 | CN1838943A Flupirtin injectable galenic form |
| 09/27/2006 | CN1838942A Compositions and methods for hydrophobic drug delivery |
| 09/27/2006 | CN1838888A Infant or follow-on formula |
| 09/27/2006 | CN1838885A Method for treatment of sores and lesions of the skin |
| 09/27/2006 | CN1838881A Insect pepellent compositions comprising dihydronepetalactone |
| 09/27/2006 | CN1837243A Cuttlebone polysaccharide CPS-1 and its preparation and use |
| 09/27/2006 | CN1837231A Immunomodulatory steroids, in particular the hemihydrate of 16, alpha-bromoepiandrosterone |
| 09/27/2006 | CN1837229A Clarithromycin derivatives and its preparation process and pharmaceutical application |
| 09/27/2006 | CN1837226A Separation of medical derivatives from phoenix-tail fern and use thereof |
| 09/27/2006 | CN1837225A Azithromycin derivatives and its preparation process and pharmaceutical application |
| 09/27/2006 | CN1837218A N2,N4-disubstituted pyrazolo [4.5-e][1,2,4] thiadiazine derivatives and use thereof |
| 09/27/2006 | CN1837215A N1,N3-disubstituted thieno[3,2-e][2,1,3] thiadiazine-2,2,4-triones derivatives and use thereof |
| 09/27/2006 | CN1837213A Bilobalide A derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1837212A Bilobalide B derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1837210A Specific penicillium ketone compounds, process for preparing same and use thereof |
| 09/27/2006 | CN1837207A Pirazino(aza)indole derivatives |
| 09/27/2006 | CN1837206A Sesquiterpene subergorgia suberosa ketone and its preparing process and application |
| 09/27/2006 | CN1837205A Process for the preparation of pyrazolopyridine tartrates |
| 09/27/2006 | CN1837202A Flavonols with blood-fat-lowering effect |
| 09/27/2006 | CN1837200A Tanshinone I derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1837199A Tanshinone I derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1837198A Tanshinone IIA derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1837197A Salvianolic acid M and rosmarinic acid as aldose reductase inhibitor in sage |
| 09/27/2006 | CN1837195A Pyridine derivatives as nmda-receptor subtype blockers |
| 09/27/2006 | CN1837194A Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 09/27/2006 | CN1836730A Intensified additive for chondroitin sulfate capsule formulation and tablet and its preparation method |
| 09/27/2006 | CN1836726A Oral liquid for treating drug addict |
| 09/27/2006 | CN1836710A Granula for cerebrovascular disease and its production method |
| 09/27/2006 | CN1836708A Aliphatic acid synthase inhibitor and method for making same and uses |
| 09/27/2006 | CN1836707A Medicine for treating tumour and its preparing method |
| 09/27/2006 | CN1836701A Scald-treating medicine |
| 09/27/2006 | CN1836684A Silktree albizzia general saponin and its extraction method, pharmaceutical use of the said composition and medicine preparation |
| 09/27/2006 | CN1836681A Ginseng stem leaves general saponin freeze-drying powder injection and its preparation method |
| 09/27/2006 | CN1836668A External use traditional Chinese medicine powder for treating acute pancreatitis |
| 09/27/2006 | CN1836667A Eye drop |
| 09/27/2006 | CN1836666A Water-soluble vitamin for injection and its preparation process and quality control method |
| 09/27/2006 | CN1836665A Pharmaceutical uses of hesperidin or its composition |
| 09/27/2006 | CN1836664A Puerarin self-emulsifying microemulsified composition and its preparation method |
| 09/27/2006 | CN1836663A Tobramycin eye drops and its preparation method |
| 09/27/2006 | CN1836662A Prulifloxacin compound preparation |
| 09/27/2006 | CN1836661A Use of aconine in medicine manufacture |
| 09/27/2006 | CN1836660A Azlocillin/clavulanic acid antibacterial composition |
| 09/27/2006 | CN1836659A Azlocillin/sulbactam antibacterial composition |
| 09/27/2006 | CN1836658A Azlocillin/tazobactam antibacterial composition |
| 09/27/2006 | CN1836657A Polymethoxylated flavones and its preparation method |
| 09/27/2006 | CN1836656A Drop pills containing sodium azulenesulfonate ingredient |
| 09/27/2006 | CN1836655A Electrolyte replenisher for treating hypopotassaemia hypomagnesemia and its uses |
| 09/27/2006 | CN1836654A Pharmaceutical composition for stabilizing ambroxol hydrochloride granula |
| 09/27/2006 | CN1836653A Rosiglitazone slow-release tablet and its preparation method |
| 09/27/2006 | CN1836651A Levogyration sulpiride injection and its preparation method |
| 09/27/2006 | CN1836511A Synergistic microbicidal combination |
| 09/27/2006 | CN1836510A Synergistic microbicidal combination |
| 09/27/2006 | CN1276970C New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 09/27/2006 | CN1276966C Decontamination of surfaces contaminated with prion-infected material with oxidizing agent-based formulations |
| 09/27/2006 | CN1276928C Cell apoptosis regulating protein related with heart failure |
| 09/27/2006 | CN1276925C Antipyretic analgesic medicine |
| 09/27/2006 | CN1276923C Crystalline polymorphic form of irinotecan hydrochloride |
| 09/27/2006 | CN1276921C Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1] octane, the preparation thereof and the application of same in therapeutics |
| 09/27/2006 | CN1276920C Thiazolidinedione derivatives and pharmaceutical composition comprising the same |
| 09/27/2006 | CN1276914C Novel cyclohexyl sulphones |
| 09/27/2006 | CN1276911C New phenyl ethyl amine compounds having beta 2-receptor excitation and its producing method |
| 09/27/2006 | CN1276776C Ointment for antipruritic and removing dandruff |
| 09/27/2006 | CN1276763C Chinese traditional medicine composition for treating bedsore and acute soft tissue injury |
| 09/27/2006 | CN1276761C Compound traditional Chinese and western medicine for treating rheumatism and osteoarthritis and productive method thereof |
| 09/27/2006 | CN1276759C Injection liquid for treating heart brain blood vessel disease and its preparation method |
| 09/27/2006 | CN1276755C Chinese medicinal effective part composition for treating cerebrovascular and cardiovascular disease |
| 09/27/2006 | CN1276754C Treatment of gastrointestinal stromal tumors |
| 09/27/2006 | CN1276753C Use of pyridine-2-yl- methylamine derivatives in the treatment of opioid dependence |
| 09/27/2006 | CN1276752C Bilobalide soft capsule and its preparation method |
| 09/27/2006 | CN1276751C Application of scutellaria root extract in preparation of anti-stomach cancer medicine |
| 09/27/2006 | CN1276750C Diclofenac sodium oral preparation |
| 09/27/2006 | CN1276749C Medicine for treating scald |
| 09/27/2006 | CN1276748C Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 09/26/2006 | US7112698 4-(c2-6alkoxy)-substituted chalcones as therapeutic agents |
| 09/26/2006 | US7112686 Precipitation from mother liquors by adding bases or acid addition salts to solution of citalopram |
| 09/26/2006 | US7112685 Labeled resiniferatoxin derivatives |
| 09/26/2006 | US7112683 Cyclic sulfone containing retroviral protease inhibitors |
| 09/26/2006 | US7112682 intermediates for N-alkylamino indoles; amination of indoles with hydroxylamine-O-sulfonic acid using organic base, aprotic solvent to form N-amino-indoles; condensation with ketone to form hydrazone; N-(n-propyl)-N-(3-fluoro-4-pyridinyl)-1H-3-methyl-indol-1-amine; large scale; by-product inhibition |
| 09/26/2006 | US7112680 Condensing a heterocyclic ketone or aldehyde with a 2-(NH2-NH-)benzimidazole, -oxazole or -thiazole; ribonucleotide reductase inhibitors; anticarcinogenic and -tumor agents; also useful against multidrug resistant cells |
| 09/26/2006 | US7112676 Pyrimido compounds having antiproliferative activity |
| 09/26/2006 | US7112675 Pyrrolotriazine inhibitors of kinases |
| 09/26/2006 | US7112673 Dibenzo [b,f]azepine intermediates |
| 09/26/2006 | US7112672 Reacting a phosphoranylidene cephem compound with acetaldehyde in the presence of a base in a solvent mixture comprising diethyl ether |
| 09/26/2006 | US7112670 Crystal form |
| 09/26/2006 | US7112669 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 09/26/2006 | US7112667 Sequences of an Ih ion channel and use thereof |
| 09/26/2006 | US7112666 Von Willebrand Factor (Vwf)-cleaving protease |